LMO2 and gene therapy for severe combined immunodeficiency [7] (multiple letters)

Alain Fischer, Salima Hacein-Bey Abina, Adrian Thrasher, Christof Von Kalle, Marina Cavazzana-Calvo, Bryan D. Stone, Terence H. Rabbitts, Matthew P. McCormack

Research output: Contribution to journalLetterOtherpeer-review

49 Citations (Scopus)
Original languageEnglish
Pages (from-to)2526-2527
Number of pages2
JournalThe New England Journal of Medicine
Volume350
Issue number24
DOIs
Publication statusPublished - 10 Jun 2004
Externally publishedYes

Cite this

Fischer, A., Hacein-Bey Abina, S., Thrasher, A., Von Kalle, C., Cavazzana-Calvo, M., Stone, B. D., Rabbitts, T. H., & McCormack, M. P. (2004). LMO2 and gene therapy for severe combined immunodeficiency [7] (multiple letters). The New England Journal of Medicine, 350(24), 2526-2527. https://doi.org/10.1056/NEJM200406103502422